Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens

PURPOSE: Selection of the most appropriate chemotherapy dosing regimens for neonates treated within the first weeks of life represents a significant clinical dilemma. Due to a lack of information relating to the clinical pharmacology of anticancer drugs in these challenging patients, current dosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Veal, Gareth J., Errington, Julie, Sastry, Jairam, Chisholm, Julia, Brock, Penelope, Morgenstern, Daniel, Pritchard-Jones, Kathy, Chowdhury, Tanzina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819938/
https://www.ncbi.nlm.nih.gov/pubmed/26875154
http://dx.doi.org/10.1007/s00280-016-2975-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819938/
https://www.ncbi.nlm.nih.gov/pubmed/26875154
http://dx.doi.org/10.1007/s00280-016-2975-0

Ejemplares similares